improving outcomes in resectable nsclc: decisions about neoadjuvant and adjuvant immunotherapy
Published 7 months ago • 435 plays • Length 52:29Download video MP4
Download video MP3
Similar videos
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
1:25
neoadjuvant therapy is taking off in lung cancer
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
2:03
improving outcomes in nsclc with perioperative targeted therapies
-
54:59
linking immunotherapy to better outcomes in resectable melanoma
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
21:36
are we closer to a cure with perioperative immunotherapy in resectable nsclc?
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
39:06
unleashing the potential of perioperative immunotherapy in resectable nsclc